SOLEX(SH:603992) Guotou Securities·2025-11-09 13:35Investment Rating - The investment rating for the company is "Buy-A" with a target price of 37.52 CNY, maintaining the rating [4]. Core Views - The company is strategically positioning itself in the high-growth robotics sector, particularly focusing on the elderly care market, which is expected to yield significant returns [3][8]. - The company has faced revenue pressure due to tariffs from the US-China trade conflict, but it is accelerating the establishment of its production base in Vietnam to mitigate these challenges [2][8]. - The company's revenue for the first three quarters of 2025 was 1.852 billion CNY, a year-on-year decrease of 15.49%, with a net profit of 159 million CNY, down 50.53% year-on-year [1][7]. Financial Performance - For Q3 2025, the company reported revenue of 712 million CNY, a decline of 4.33% year-on-year, and a net profit of 66 million CNY, down 34.10% year-on-year [1]. - The gross margin for the first three quarters of 2025 was 33.12%, a decrease of 2.28 percentage points year-on-year, while the net profit margin was 8.57%, down 6.07 percentage points year-on-year [7]. - The company is expected to achieve revenues of 3.047 billion CNY in 2025, with a projected net profit of 312 million CNY, reflecting a year-on-year decline of 30.12% [9][10]. Business Development - The company is developing its robotics business, focusing on both B2B and B2C segments, including logistics and care service robots, with plans to launch products in Q4 2025 [3][8]. - The Vietnam production base is expected to play a crucial role in expanding the company's market presence in the US and mitigating tariff impacts [2][8]. Market Outlook - The company anticipates a revenue growth of 1.06%, 12.48%, and 12.83% for the years 2025, 2026, and 2027, respectively, while net profit is expected to recover in 2026 and 2027 [8][9].